Jon P. Stonehouse - Sep 1, 2022 Form 4/A - Amendment Insider Report for BELLICUM PHARMACEUTICALS, INC (BLCM)

Role
Director
Signature
/s/ Richard A. Fair, Attorney-in-Fact
Stock symbol
BLCM
Transactions as of
Sep 1, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
1/4/2023, 07:08 PM
Date Of Original Report
Sep 2, 2022
Previous filing
Jun 16, 2022
Next filing
Dec 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLCM Common Stock Options Exercise $0 +60.6K +274.69% $0.00 82.6K Sep 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the mathematical error in the total amount of securities beneficially owned following the reported transaction on the original Form 4 filed with the SEC on September 2, 2022.